This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Illumina Croissance future
Future contrôle des critères 3/6
Illumina is forecast to grow earnings and revenue by 45.6% and 5.9% per annum respectively while EPS is expected to grow by 54.2% per annum.
Informations clés
45.6%
Taux de croissance des bénéfices
54.2%
Taux de croissance du BPA
Life Sciences croissance des bénéfices | 17.6% |
Taux de croissance des recettes | 5.9% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Good |
Dernière mise à jour | 27 Jun 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 5,081 | 1,114 | 1,283 | 1,449 | 7 |
12/31/2025 | 4,742 | 803 | 1,528 | 1,068 | 8 |
12/31/2024 | 4,444 | 496 | 1,414 | 1,360 | 8 |
3/31/2024 | 4,493 | -1,290 | 366 | 545 | N/A |
12/31/2023 | 4,504 | -1,161 | 282 | 478 | N/A |
10/1/2023 | 4,465 | -1,125 | 168 | 401 | N/A |
7/2/2023 | 4,461 | -4,186 | -224 | 210 | N/A |
4/2/2023 | 4,448 | -4,487 | -228 | 230 | N/A |
1/1/2023 | 4,584 | -4,404 | -74 | 392 | N/A |
10/2/2022 | 4,700 | -4,153 | 79 | 527 | N/A |
7/3/2022 | 4,693 | -20 | 53 | 307 | N/A |
4/3/2022 | 4,656 | 701 | 208 | 435 | N/A |
1/2/2022 | 4,526 | 762 | 337 | 545 | N/A |
10/3/2021 | 4,280 | 907 | 469 | 669 | N/A |
7/4/2021 | 3,966 | 769 | 898 | 1,094 | N/A |
4/4/2021 | 3,473 | 630 | 890 | 1,081 | N/A |
1/3/2021 | 3,239 | 656 | 891 | 1,080 | N/A |
9/27/2020 | 3,238 | 638 | 933 | 1,117 | N/A |
6/28/2020 | 3,351 | 693 | 1,046 | 1,231 | N/A |
3/29/2020 | 3,556 | 942 | 941 | 1,134 | N/A |
12/29/2019 | 3,543 | 1,002 | 842 | 1,051 | N/A |
9/29/2019 | 3,458 | 973 | 691 | 908 | N/A |
6/30/2019 | 3,405 | 938 | 701 | 933 | N/A |
3/31/2019 | 3,397 | 851 | 823 | 1,085 | N/A |
12/30/2018 | 3,333 | 826 | 846 | 1,142 | N/A |
9/30/2018 | 3,243 | 684 | 829 | 1,136 | N/A |
7/1/2018 | 3,103 | 648 | 752 | 1,079 | N/A |
4/1/2018 | 2,936 | 567 | 643 | 962 | N/A |
12/31/2017 | 2,752 | 725 | N/A | 875 | N/A |
10/1/2017 | 2,594 | 775 | N/A | 843 | N/A |
7/2/2017 | 2,487 | 741 | N/A | 784 | N/A |
4/2/2017 | 2,424 | 730 | N/A | 848 | N/A |
1/1/2017 | 2,398 | 454 | N/A | 779 | N/A |
10/2/2016 | 2,371 | 440 | N/A | 757 | N/A |
7/3/2016 | 2,314 | 430 | N/A | 762 | N/A |
4/3/2016 | 2,253 | 415 | N/A | 692 | N/A |
1/3/2016 | 2,220 | 462 | N/A | 786 | N/A |
9/27/2015 | 2,141 | 510 | N/A | 560 | N/A |
6/28/2015 | 2,071 | 486 | N/A | 524 | N/A |
3/29/2015 | 1,979 | 430 | N/A | 531 | N/A |
12/28/2014 | 1,861 | 353 | N/A | 501 | N/A |
9/28/2014 | 1,736 | 281 | N/A | 488 | N/A |
6/29/2014 | 1,612 | 219 | N/A | 425 | N/A |
3/30/2014 | 1,511 | 208 | N/A | 336 | N/A |
12/29/2013 | 1,421 | 125 | N/A | 386 | N/A |
9/29/2013 | 1,343 | 117 | N/A | 338 | N/A |
6/30/2013 | 1,272 | 115 | N/A | 307 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: ILMN.V is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Bénéfices vs marché: ILMN.V is forecast to become profitable over the next 3 years, which is considered above average market growth.
Croissance élevée des bénéfices: ILMN.V is expected to become profitable in the next 3 years.
Chiffre d'affaires vs marché: ILMN.V's revenue (5.9% per year) is forecast to grow slower than the US market (8.7% per year).
Croissance élevée des revenus: ILMN.V's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if ILMN.V's Return on Equity is forecast to be high in 3 years time